This law was enacted a full 18 years later than the United States 'Orphan Drugs Act. But legislator Chiang Chi-wen, who promoted the bill, says the new statute will benefit not only patients and their families, but also the government.
雖然「罕見疾病防治及藥物法」較美國的「孤兒藥品法案」足足晚了十八年，推動立法的立法委員江綺雯指出，法案通過是病患、家屬、政府三贏的局面。